SE9602644D0 - New use - Google Patents

New use

Info

Publication number
SE9602644D0
SE9602644D0 SE9602644A SE9602644A SE9602644D0 SE 9602644 D0 SE9602644 D0 SE 9602644D0 SE 9602644 A SE9602644 A SE 9602644A SE 9602644 A SE9602644 A SE 9602644A SE 9602644 D0 SE9602644 D0 SE 9602644D0
Authority
SE
Sweden
Prior art keywords
optionally
treatment
new use
plasticizer
medicament
Prior art date
Application number
SE9602644A
Other languages
Swedish (sv)
Inventor
Birgitta Jensfelt
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9602644A priority Critical patent/SE9602644D0/en
Publication of SE9602644D0 publication Critical patent/SE9602644D0/en
Priority to AU34700/97A priority patent/AU3470097A/en
Priority to PCT/SE1997/001122 priority patent/WO1998001112A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Use of a hydrogel formulation consisting essentially of (i) one or more gelling agents; (ii) water; (iii) optionally a pH-adjusting agent; (iv) optionally a plasticizer; and (v) optionally a surfactant; for the manufacture of a medicament for the treatment of distal inflammatory bowel diseases, in particular for the rectal treatment of ulcerative colitis. This novel use is advantageous in that no local anaesthetics or other active ingredients are required in order to achieve satisfactory relief upon treatment.
SE9602644A 1996-07-04 1996-07-04 New use SE9602644D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9602644A SE9602644D0 (en) 1996-07-04 1996-07-04 New use
AU34700/97A AU3470097A (en) 1996-07-04 1997-06-19 New use of a hydrogel formulation
PCT/SE1997/001122 WO1998001112A1 (en) 1996-07-04 1997-06-19 New use of a hydrogel formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602644A SE9602644D0 (en) 1996-07-04 1996-07-04 New use

Publications (1)

Publication Number Publication Date
SE9602644D0 true SE9602644D0 (en) 1996-07-04

Family

ID=20403274

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9602644A SE9602644D0 (en) 1996-07-04 1996-07-04 New use

Country Status (3)

Country Link
AU (1) AU3470097A (en)
SE (1) SE9602644D0 (en)
WO (1) WO1998001112A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1017404E (en) * 1997-09-26 2004-11-30 Celltech Pharma Europ Ltd PHARMACEUTICAL FORMULA FOR THE TREATMENT OF INFLAMMATORY DISEASE OF THE INTESTINE
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
NZ549469A (en) 2001-02-15 2009-02-28 Access Pharma Inc Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
AU2002309180A1 (en) * 2002-04-24 2003-11-10 Medicarb Ab Composition and kit for the treatment of inflammatory bowel diseases
CN105358095B (en) * 2013-04-08 2020-11-20 雷金蒂斯公司 Methods and compositions for treating inflammatory bowel disease without colectomy
WO2015143310A1 (en) 2014-03-21 2015-09-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix
AU2017235321A1 (en) 2016-03-14 2018-11-01 Regentys Corporation Method and composition for treating inflammatory Bowel Disease
AU2018251210A1 (en) 2017-04-14 2019-11-28 Gelesis Llc Compositions and methods for treating or preventing gut permeability-related disorders
WO2023153861A1 (en) * 2022-02-10 2023-08-17 코아스템켐온 주식회사 Pharmaceutical composition comprising curcumin and ginsenoside, and formulation thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930005A (en) * 1973-06-15 1975-12-30 Squibb & Sons Inc Antiinflammatory agents and their use
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
IE59361B1 (en) * 1986-01-24 1994-02-09 Akzo Nv Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension

Also Published As

Publication number Publication date
WO1998001112A1 (en) 1998-01-15
AU3470097A (en) 1998-02-02

Similar Documents

Publication Publication Date Title
NO20001567D0 (en) Bioadhesive compositions and methods for topical administration of active agents
IS4146A (en) A pharmaceutical preparation for oral administration of proton pump blockers
UA41989C2 (en) Pharmaceutical composition in form of gel for treating skin diseases and method for treating infected skin
ES2163530T3 (en) DISMUTASA SUPEROXIDE APPLICATION (SOD) IN LIPOSOMAS.
EP0280737A4 (en) Steroidal drug-containing preparation for external use.
ATE286655T1 (en) ROOM TEMPERATURE STERILIZING AGENT
ATE370730T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING CHELATING/SEQUESTING AGENTS AND THEIR DERMATOLOGICAL USE
SE9602644D0 (en) New use
SE8701921D0 (en) NEW PHARMACEUTICAL APPLICATION
DK1450771T3 (en) Pharmaceutical compositions for treating skin lesions and mucous membranes and methods and kits for their use
DK0856312T3 (en) Use of trospium chloride for the manufacture of a medicament for the treatment of bladder diseases
AU3324100A (en) Use of pirenoxine for the protection of corneal tissues in photokeratectomy
TW349865B (en) Therapeutic agent for hemorrhoidal diseases
ES2153501T3 (en) AGENT FOR HAIR TREATMENT.
ATE92303T1 (en) PERIODONTIC COMPOSITION AND PROCESS.
AR026257A1 (en) N-GUANIDINOALQUILAMIDAS, ITS PREPARATION, ITS USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK1194109T3 (en) Topical formulations comprising skin permeation agents and their use
YU13599A (en) Use of pharmaceutical composition for preparation of medicament in a gel form